Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Market Cap	1.68B -6.6%
Revenue (ttm)	1.37B +16.1%
Net Income	238.11M -62.1%
EPS	0.16 -62.7%
Shares Out	1.50B
PE Ratio	7.19
Forward PE	n/a
Dividend	0.06 (5.53%)
Ex-Dividend Date	May 27, 2026

Volume	24,000
Average Volume	189,000
Open	1.130
Previous Close	1.140
Day's Range	1.120 - 1.130
52-Week Range	1.060 - 1.470
Beta	0.26
RSI	47.03
Earnings Date	Mar 27, 2026

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-all...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 1,116
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2348

Financial Performance

In 2025, HKG:2348's revenue was 1.23 billion, an increase of 16.09% compared to the previous year's 1.06 billion. Earnings were 213.97 million, a decrease of -62.13%.

Financial numbers in CNY